Central America vs El Salvador: Proportion of the target population who received a 3rd dose of
Central America
80.0%
in 2024
El Salvador
96.0%
in 2024
Central America rank
13th
El Salvador rank
16th
Proportion of the target population who received a 3rd dose of over time
- Central America
- El Salvador
How they compare
El Salvador currently reports 96.0% against 80.0% in Central America, a difference of 16.0%.
That makes El Salvador's figure about 1.2 times Central America's.
The two have swapped places 5 times across 15 shared years of data; in 2010 it was Central America ahead.
Central America ranks 13th and El Salvador ranks 16th of 37 groups.
El Salvador has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Central America | El Salvador | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 86.5% | 91.0% | 4.5% | El Salvador |
| 2020s | 81.4% | 94.0% | 12.6% | El Salvador |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received a 3rd dose of, Central America or El Salvador?
- El Salvador, at 96.0% against 80.0% in Central America as of 2024.
- What is the difference in proportion of the target population who received a 3rd dose of between Central America and El Salvador?
- 16.0%, with El Salvador ahead.
- How many years of comparable data are there for Central America and El Salvador?
- 15 years are reported by both, from 2010 to 2024.
- How do Central America and El Salvador rank globally for proportion of the target population who received a 3rd dose of?
- Central America ranks 13th and El Salvador ranks 16th of 37 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.